ANN ARBOR, Mich., June 10, 2021 – Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced that it has appointed healthcare and molecular diagnostics veteran and former Abbott executive Mark Szewczyk as Chief Commercial Officer. The addition of Szewczyk is the latest in a series of strategic appointments bolstering Strata Oncology’s commercial team, following the appointment of Trey Regalo as Vice President of Sales and Rob Manor as Vice President of Commercial Partnerships.

“We are thrilled to welcome Mark to Strata Oncology. Successful cancer management requires collaboration, and nobody understands that better than Mark, who has decades of experience in leading teams that deliver exceptional results,” said Dan Rhodes, Ph.D., co-founder and Chief Executive Officer, Strata Oncology. “His proven leadership in commercial strategy and extensive experience in molecular diagnostics will be vital to our efforts to bring the right treatment to patients with cancer through precision medicine.”

Read more here.